Carme Fàbrega

1.5k total citations
45 papers, 1.2k citations indexed

About

Carme Fàbrega is a scholar working on Molecular Biology, Biomedical Engineering and Infectious Diseases. According to data from OpenAlex, Carme Fàbrega has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 4 papers in Biomedical Engineering and 2 papers in Infectious Diseases. Recurrent topics in Carme Fàbrega's work include Advanced biosensing and bioanalysis techniques (29 papers), DNA and Nucleic Acid Chemistry (27 papers) and RNA Interference and Gene Delivery (22 papers). Carme Fàbrega is often cited by papers focused on Advanced biosensing and bioanalysis techniques (29 papers), DNA and Nucleic Acid Chemistry (27 papers) and RNA Interference and Gene Delivery (22 papers). Carme Fàbrega collaborates with scholars based in Spain, United States and Italy. Carme Fàbrega's co-authors include Ramón Eritja, Christopher D. Lima, Stewart Shuman, Anna Aviñó, Vincent K. Shen, María Tintoré, Stéphane Hausmann, Andreia F. Jorge, Hudan Liu and Megerditch Kiledjian and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Carme Fàbrega

41 papers receiving 1.2k citations

Peers

Countries citing papers authored by Carme Fàbrega

Since Specialization

Citations

This map shows the geographic impact of Carme Fàbrega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carme Fàbrega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carme Fàbrega more than expected).

Fields of papers citing papers by Carme Fàbrega

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carme Fàbrega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carme Fàbrega. The network helps show where Carme Fàbrega may publish in the future.

Co-authorship network of co-authors of Carme Fàbrega

This figure shows the co-authorship network connecting the top 25 collaborators of Carme Fàbrega. A scholar is included among the top collaborators of Carme Fàbrega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carme Fàbrega. Carme Fàbrega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted Tumor Microenvironment Delivery of Floxuridine Prodrug via Soluble Silica Nanoparticles in Malignant Melanoma as a Model for Aggressive Cancer Treatment 2025 ·Small ·(unknown), (unknown), (unknown), (unknown), Anna Aviñó, Ramón Eritja, Carme Fàbrega, Lorena García‐Hevia, Mónica L. Fanárraga	1
2	Modified Bis-pyrimidine Clamps for Triplex Formation and Their Use in SARS-CoV-2 Detection 2025 ·ACS Omega ·(unknown), Raimundo Gargallo, (unknown), Irene Gómez‐Pinto, Carme Fàbrega, Jesús M. de la Fuente, Masad J. Damha, Carlos González, Ramón Eritja, Anna Aviñó	1
3	On the interaction of anticancer G-quadruplex ligands with GalNAc-functionalized G-quadruplex-forming carriers for selective recognition and treatment of hepatocellular carcinoma 2025 ·Bioorganic Chemistry ·(unknown), Carme Fàbrega, Domenica Musumeci, Filippo Doria, Valentina Pirota, Francesca Ghirga, Chiara Platella, Ramón Eritja, Daniela Montesarchio	0
4	Aptamer-Hytac Chimeras for Targeted Degradation of SARS-CoV-2 Spike-1 2024 ·Cells ·Carme Fàbrega, (unknown), Alice Zuin, (unknown), (unknown), Gemma Fabriàs, Ramón Eritja, Bernat Crosas	1
5	Aptamer-Drug conjugates for a targeted and synergistic anticancer Response: Exploiting T30923-5-fluoro-2′-deoxyuridine (INT-FdU) derivatives 2024 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), Anna Aviñó, Veronica Esposito, Aldo Galeone, Antonella Virgilio, Carme Fàbrega, Ramón Eritja	2
6	Lipid and Peptide-Oligonucleotide Conjugates for Therapeutic Purposes: From Simple Hybrids to Complex Multifunctional Assemblies 2023 ·Pharmaceutics ·Carme Fàbrega, Anna Aviñó, (unknown), Andreia F. Jorge, Santiago Grijalvo, Ramón Eritja	17
7	Synthesis of 2′-O-Methyl/2′-O-MOE-L-Nucleoside Derivatives and Their Applications: Preparation of G-Quadruplexes, Their Characterization, and Stability Studies 2023 ·ACS Omega ·(unknown), (unknown), Carme Fàbrega, Susana Fernández, Yogesh S. Sanghvi, Miguel Ferrero, Ramón Eritja	0
8	Chemical Modifications in Nucleic Acids for Therapeutic and Diagnostic Applications 2021 ·The Chemical Record ·Carme Fàbrega, Anna Aviñó, Ramón Eritja	15
9	Oligonucleotides Carrying Nucleoside Antimetabolites as PotentialProdrugs 2021 ·Current Medicinal Chemistry ·Carme Fàbrega, (unknown), Ramón Eritja, Anna Aviñó	6
10	DNA-based nanoscaffolds as vehicles for 5-fluoro-2′-deoxyuridine oligomers in colorectal cancer therapy 2018 ·Nanoscale ·Andreia F. Jorge, Anna Aviñó, Alberto A. C. C. Pais, Ramón Eritja, Carme Fàbrega	51
11	The effect of l-thymidine, acyclic thymine and 8-bromoguanine on the stability of model G-quadruplex structures 2016 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Anna Aviñó, Stefania Mazzini, Carme Fàbrega, Pablo Peñalver, Raimundo Gargallo, Juan Carlos Morales, Ramón Eritja	11
12	Synthesis of oligonucleotides carrying fluorescently labelled O6-alkylguanine for measuring hAGT activity 2015 ·Bioorganic & Medicinal Chemistry Letters ·María Tintoré, Santiago Grijalvo, Ramón Eritja, Carme Fàbrega	5
13	DNA Origami as a DNA Repair Nanosensor at the Single‐Molecule Level 2013 ·Angewandte Chemie International Edition ·María Tintoré, Isaac Gállego, Brendan D. Manning, Ramón Eritja, Carme Fàbrega	56
14	Thrombin Binding Aptamer, More than a Simple Aptamer: Chemically Modified Derivatives and Biomedical Applications 2012 ·Current Pharmaceutical Design ·Anna Aviñó, Carme Fàbrega, María Tintoré, Ramón Eritja	117
15	Development of a Novel Fluorescence Assay Based on the Use of the Thrombin‐Binding Aptamer for the Detection of O⁶‐Alkylguanine‐DNA Alkyltransferase Activity 2010 ·Journal of Nucleic Acids ·María Tintoré, Anna Aviñó, Federico M. Ruiz, Ramón Eritja, Carme Fàbrega	21
16	Encephalitozoon cuniculi mRNA Cap (Guanine N-7) Methyltransferase 2005 ·Journal of Biological Chemistry ·Stéphane Hausmann, (unknown), Carme Fàbrega, Stewart W. Schneller, Christopher D. Lima, Stewart Shuman	36
17	Structure and Mechanism of mRNA Cap (Guanine-N7) Methyltransferase 2004 ·Molecular Cell ·Carme Fàbrega, Stéphane Hausmann, Vincent K. Shen, Stewart Shuman, Christopher D. Lima	135
18	Insights into the Structure, Mechanism, and Regulation of Scavenger mRNA Decapping Activity 2004 ·Molecular Cell ·Meigang Gu, Carme Fàbrega, (unknown), Hudan Liu, Megerditch Kiledjian, Christopher D. Lima	104
19	Synthesis and properties of oligonucleotides containing the mutagenic base O4-benzylthymidine 1995 ·Bioorganic & Medicinal Chemistry ·Carme Fàbrega, Ramón Eritja, Nanda D. Sinha, Manjit Dosanjh, (unknown)	7
20	A simple method for N-15 labelling of exocyclic amino groups in synthetic oligodeoxynucleotides 1994 ·Nucleic Acids Research ·(unknown), Carme Fàbrega, (unknown), Myron F. Goodman, Patricia A. Fagan, David E. Wemmer, Ramón Eritja	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact